Gavins Felicity
I am a senior writer at BP Journal. I am tasked with creating content that provides information about and analyzes financial markets, the economy and all things money-related. I have Master's in Business Administration with major in Finance.
Recent Post
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) experienced a remarkable 53.17% spike in its stock price, closing at $3.14 on November 18, 2024, following...
